Eva Wiberg-Itzel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Eva Wiberg-Itzel has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
Helena Åkerud
Department of Immunology, Genetics, and Pathology, Minerva Fertility Clinic, Uppsala University, Uppsala, Sweden
9 shared publicationsHelena Akerud
Department of Immunology Genetics and Pathology, Uppsala University Sweden, Uppsala, Sweden
7 shared publicationsIrene Sterpu
Division of Obstetrics and Gynecology, Department of Clinical Sciences, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden
5 shared publicationsTove Wallstrom
Department of Clinical Science and Education, Karolinska Institute, Soder Hospital
5 shared publicationsBirger Winbladh
Department of Clinical Science and education, Karolinska Institutet, Södersjukhuset, Stockholm, Sweden
4 shared publications- Lennart Nordström
Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden
4 shared publications
Latest Publications
- Open Access
- 22 January 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 307, 43-48
The impact of lowering the blood glucose cut-off values in gestational diabetes mellitus on maternal and perinatal outcomes
- 22 January 2025
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 307, 43-48
Open AccessThe impact of lowering the blood glucose cut-off values in gestational diabetes mellitus on maternal and perinatal outcomes
- Open Access
- 1 December 2021
- Published by Elsevier in Primary Care Diabetes
- Vol. 15 (6) , 1040-1051
Swedish guidelines for type 1 diabetes and pregnancy outcomes: A nationwide descriptive study of consensus and adherence
- 1 December 2021
- Published by Elsevier in Primary Care Diabetes
- Vol. 15 (6) , 1040-1051
Open AccessSwedish guidelines for type 1 diabetes and pregnancy outcomes: A nationwide descriptive study of consensus and adherence
- Open Access
- 10 November 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 7306-7311
Amniotic fluid lactate (AFL): a new predictor of labor outcome in dystocic deliveries
Purpose of this Review: Even today, hundreds of thousands of women die or suffer high levels of morbidity associated with childbirth. One of the most common causes is halted labor progress, or labor dystocia. There have been no developments in the diagnosis or treatment of dystocic deliveries since Friedman designed the Partogram in the 1950s. Oxytocin is the only treatment for dystocic labor. Sometimes, oxytocin is a lifesaver for the woman, especially in severe postpartum hemorrhages. At the same time, it is also one of the most overused drugs in obstetric care. This review article is meant to provide a short overview of the current knowledge of uterine metabolism during labor, uterine lactate production, and its association with labor dystocia. The article also intends to reflect new ways of thinking regarding practical recommendations for treating labor dystocia and offer a look at the future of dystocic labor management.
- 10 November 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 7306-7311
Open AccessAmniotic fluid lactate (AFL): a new predictor of labor outcome in dystocic deliveries
Purpose of this Review: Even today, hundreds of thousands of women die or suffer high levels of morbidity associated with childbirth. One of the most common causes is halted labor progress, or labor dystocia. There have been no developments in the diagnosis or treatment of dystocic deliveries since Friedman designed the Partogram in the 1950s. Oxytocin is the only treatment for dystocic labor. Sometimes, oxytocin is a lifesaver for the woman, especially in severe postpartum hemorrhages. At the same time, it is also one of the most overused drugs in obstetric care. This review article is meant to provide a short overview of the current knowledge of uterine metabolism during labor, uterine lactate production, and its association with labor dystocia. The article also intends to reflect new ways of thinking regarding practical recommendations for treating labor dystocia and offer a look at the future of dystocic labor management.
- Open Access
- 25 October 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 8521-8529
Body mass index and labor outcome associated with the level of amniotic fluid lactate. A cross-sectional study of women with labor dystocia
- 25 October 2021
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (25) , 8521-8529
Open AccessBody mass index and labor outcome associated with the level of amniotic fluid lactate. A cross-sectional study of women with labor dystocia
- Open Access
- 4 May 2021
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 21 (1) , 1-10
Women’s expectations and experiences of labor induction – a questionnaire-based analysis of a randomized controlled trial
Background: Although labor induction is a commonly used procedure in obstetrical care, there are limited data on its psycho-emotional effects on the woman. This study analysed the expectations and experiences of women in different routes of labor induction. The study’s primary aim was to compare women’s delivery experience if induced by orally administrated misoprostol (OMS) compared with misoprostol vaginal insert (MVI). Secondly, an evaluation of women’s general satisfaction with induced labor was made, and factors associated with a negative experience. Methods: Primiparous women (n = 196) with a singleton fetus in cephalic presentation, ≥ 37 weeks of gestation, with a Bishop’s score ≤ 4 planning labor induction were randomly allocated to receive either OMS (Cytotec®) or MVI (Misodel®). Data were collected by validated questionnaires, the Wijma Delivery Expectation/Experience Questionnaire (A + B). The pre-labor part of the survey (W-DEQ version A) was given to participants to complete within 1 hour before the start of induction, and the post-labor part of the questionnaire (W-DEQ version B) was administered after birth and collected before the women were discharged from hospital. Results: It was found that 11.8% (17/143) reported a severe fear of childbirth (W-DEQ A score ≥ 85). Before the induction, women with extreme fear had 3.7 times increased risk of experiencing labor induction negatively (OR 3.7 [95% CI, 1.04–13.41]). Conclusion: No difference was identified between OMS and MVI when delivery experience among women induced to labor was analysed. Severe fear of childbirth before labor was a risk factor for a negative experience of labor induction. Trial registration: Clinical trial register number NCT02918110. Date of registration on May 31, 2016.
- 4 May 2021
- Published by Springer Nature in BMC Pregnancy and Childbirth
- Vol. 21 (1) , 1-10
Open AccessWomen’s expectations and experiences of labor induction – a questionnaire-based analysis of a randomized controlled trial
Background: Although labor induction is a commonly used procedure in obstetrical care, there are limited data on its psycho-emotional effects on the woman. This study analysed the expectations and experiences of women in different routes of labor induction. The study’s primary aim was to compare women’s delivery experience if induced by orally administrated misoprostol (OMS) compared with misoprostol vaginal insert (MVI). Secondly, an evaluation of women’s general satisfaction with induced labor was made, and factors associated with a negative experience. Methods: Primiparous women (n = 196) with a singleton fetus in cephalic presentation, ≥ 37 weeks of gestation, with a Bishop’s score ≤ 4 planning labor induction were randomly allocated to receive either OMS (Cytotec®) or MVI (Misodel®). Data were collected by validated questionnaires, the Wijma Delivery Expectation/Experience Questionnaire (A + B). The pre-labor part of the survey (W-DEQ version A) was given to participants to complete within 1 hour before the start of induction, and the post-labor part of the questionnaire (W-DEQ version B) was administered after birth and collected before the women were discharged from hospital. Results: It was found that 11.8% (17/143) reported a severe fear of childbirth (W-DEQ A score ≥ 85). Before the induction, women with extreme fear had 3.7 times increased risk of experiencing labor induction negatively (OR 3.7 [95% CI, 1.04–13.41]). Conclusion: No difference was identified between OMS and MVI when delivery experience among women induced to labor was analysed. Severe fear of childbirth before labor was a risk factor for a negative experience of labor induction. Trial registration: Clinical trial register number NCT02918110. Date of registration on May 31, 2016.
- 13 January 2021
- Published by Springer Nature in Journal of Plant Growth Regulation
- Vol. 40 (6) , 2259-2275
Insights into the Role of Gasotransmitters Mediating Salt Stress Responses in Plants
- 13 January 2021
- Published by Springer Nature in Journal of Plant Growth Regulation
- Vol. 40 (6) , 2259-2275
Insights into the Role of Gasotransmitters Mediating Salt Stress Responses in Plants
- Open Access
- 1 December 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (23) , 4543-4551
Predictive factors in pregnancies with reduced fetal movements: a pilot study
Pregnancies with reduced fetal movements (RFM) are at risk for poor neonatal outcomes and stillbirth. To investigate whether Doppler measurements or angiogenic factors are good predictors of advers...
- 1 December 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (23) , 4543-4551
Open AccessPredictive factors in pregnancies with reduced fetal movements: a pilot study
Pregnancies with reduced fetal movements (RFM) are at risk for poor neonatal outcomes and stillbirth. To investigate whether Doppler measurements or angiogenic factors are good predictors of advers...
- Open Access
- 19 March 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (6) , 1100-1107
Fetal scalp blood sampling during second stage of labor – analyzing lactate or pH? A secondary analysis of a randomized controlled trial
Background: Cardiotocography (CTG) is a widely used method for assessing fetal wellbeing during labor. It is well-known that CTG has high sensitivity but low specificity. To avoid unnecessary operative interventions, adjunctive methods such as fetal blood sampling (FBS) are used. Few studies have looked into whether FBS can be used during second stage of labor, and in that case, which of the methods (lactate or pH) are preferred. Objective: To evaluate clinical effectiveness of measuring lactate versus pH in preventing birth acidemia when FBS was performed during second stage of labor. Methods: Secondary analysis of a randomized controlled trial . Thousand three hundred and thirty-eight women with a singleton pregnancy, cephalic presentation, gestational age ≥34 weeks, and indication for FBS during second stage of labor were included. Main outcome measures: Metabolic acidemia (pH 12 mmol/l) or pH < 7.00 in cord arterial blood at birth. Secondary outcomes: A composite outcome (metabolic acidemia, pH <7 or Apgar score <4), and rates of operative deliveries. Results: Metabolic acidemia occurred in 4.1% in the lactate versus 5.1% in the pH group (relative risk (RR): 0.80; 95% confidence interval (CI): 0.48–1.35) and pH <7 in 1.4% versus 2.8% (RR: 0.51, 95% CI: 0.23–1.13). Composite outcome was found in 3.8 versus 4.9%, respectively (RR: 0.76; 95% CI: 0.46–1.26). No difference in total operative interventions was found. More cesarean deliveries were performed in the lactate group (16.5 vs. 12.4%; RR: 1.33; 95% CI: 1.02–1.74). Conclusion: When analyzing lactate or pH in fetal scalp blood during second stage of labor neonatal outcomes were comparable. The frequency of total operative interventions was similar but more cesarean deliveries were performed in the lactate group.
- 19 March 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (6) , 1100-1107
Open AccessFetal scalp blood sampling during second stage of labor – analyzing lactate or pH? A secondary analysis of a randomized controlled trial
Background: Cardiotocography (CTG) is a widely used method for assessing fetal wellbeing during labor. It is well-known that CTG has high sensitivity but low specificity. To avoid unnecessary operative interventions, adjunctive methods such as fetal blood sampling (FBS) are used. Few studies have looked into whether FBS can be used during second stage of labor, and in that case, which of the methods (lactate or pH) are preferred. Objective: To evaluate clinical effectiveness of measuring lactate versus pH in preventing birth acidemia when FBS was performed during second stage of labor. Methods: Secondary analysis of a randomized controlled trial . Thousand three hundred and thirty-eight women with a singleton pregnancy, cephalic presentation, gestational age ≥34 weeks, and indication for FBS during second stage of labor were included. Main outcome measures: Metabolic acidemia (pH 12 mmol/l) or pH < 7.00 in cord arterial blood at birth. Secondary outcomes: A composite outcome (metabolic acidemia, pH <7 or Apgar score <4), and rates of operative deliveries. Results: Metabolic acidemia occurred in 4.1% in the lactate versus 5.1% in the pH group (relative risk (RR): 0.80; 95% confidence interval (CI): 0.48–1.35) and pH <7 in 1.4% versus 2.8% (RR: 0.51, 95% CI: 0.23–1.13). Composite outcome was found in 3.8 versus 4.9%, respectively (RR: 0.76; 95% CI: 0.46–1.26). No difference in total operative interventions was found. More cesarean deliveries were performed in the lactate group (16.5 vs. 12.4%; RR: 1.33; 95% CI: 1.02–1.74). Conclusion: When analyzing lactate or pH in fetal scalp blood during second stage of labor neonatal outcomes were comparable. The frequency of total operative interventions was similar but more cesarean deliveries were performed in the lactate group.
- Open Access
- 4 September 2019
- Published by Springer Nature in Research Square
Women´s expectations and experiences of labour induction—a questionnaire-based analysis of a randomised controlled trial
Background: Although the induction of labour is a commonly used procedure in obstetrical care, there are limited data on its psycho-emotional effects on the woman. This study analysed the expectations and experiences of women included in a randomised controlled trial comparing different routes of labour induction. The primary aim of this questionnaire-based study was to evaluate women’s general satisfaction with induced labours and identify factors associated with a negative experience. The secondary aim was to compare the orally administrated misoprostol (OMS) to a misoprostol vaginal insert (MVI), while focusing on general maternal satisfaction. Methods Primiparous women (n = 196) with a singleton foetus in cephalic presentation, ≥ 37 weeks of gestation, with a Bishop´s score ≤ 4 planning labour induction were randomly allocated to receive either OMS (Cytotec®) or MVI (Misodel®). Data were collected by validated questionnaires, the Wijma Delivery Expectation/Experience Questionnaire (A+B). The pre-labour part of the questionnaire (W-DEQ version A) was given to participants to complete within one hour before the start of induction, and the post-labour part of the questionnaire (W-DEQ version B) was administered after birth and collected before the women were discharged from hospital. Background characteristics and delivery outcomes were extracted from maternity files and correlated to the results from the questionnaires. Results The mean score of the post-labour questionnaire (W-DEQ B) was 61.2 (22.9) and OMS and MVI generated comparable experiences among the participating women with a W-DEQ B score of 59.4 (21.0) and 62.7 (24.7), respectively (p = 0.48). It was found that 11.8% (17/143) reported a severe fear of childbirth (W-DEQ A score ≥ 85). Women that stated a severe fear before the start of induction had a 3.7 times increased risk of experiencing labour induction negatively (OR 3.7 [95% CI; 1.04–13.41]). Conclusion Severe fear of childbirth was a risk factor for a negative experience of labour induction. OMS compared to MVI generated comparable results among participating women in this randomised controlled trial.
- 4 September 2019
- Published by Springer Nature in Research Square
Open AccessWomen´s expectations and experiences of labour induction—a questionnaire-based analysis of a randomised controlled trial
Background: Although the induction of labour is a commonly used procedure in obstetrical care, there are limited data on its psycho-emotional effects on the woman. This study analysed the expectations and experiences of women included in a randomised controlled trial comparing different routes of labour induction. The primary aim of this questionnaire-based study was to evaluate women’s general satisfaction with induced labours and identify factors associated with a negative experience. The secondary aim was to compare the orally administrated misoprostol (OMS) to a misoprostol vaginal insert (MVI), while focusing on general maternal satisfaction. Methods Primiparous women (n = 196) with a singleton foetus in cephalic presentation, ≥ 37 weeks of gestation, with a Bishop´s score ≤ 4 planning labour induction were randomly allocated to receive either OMS (Cytotec®) or MVI (Misodel®). Data were collected by validated questionnaires, the Wijma Delivery Expectation/Experience Questionnaire (A+B). The pre-labour part of the questionnaire (W-DEQ version A) was given to participants to complete within one hour before the start of induction, and the post-labour part of the questionnaire (W-DEQ version B) was administered after birth and collected before the women were discharged from hospital. Background characteristics and delivery outcomes were extracted from maternity files and correlated to the results from the questionnaires. Results The mean score of the post-labour questionnaire (W-DEQ B) was 61.2 (22.9) and OMS and MVI generated comparable experiences among the participating women with a W-DEQ B score of 59.4 (21.0) and 62.7 (24.7), respectively (p = 0.48). It was found that 11.8% (17/143) reported a severe fear of childbirth (W-DEQ A score ≥ 85). Women that stated a severe fear before the start of induction had a 3.7 times increased risk of experiencing labour induction negatively (OR 3.7 [95% CI; 1.04–13.41]). Conclusion Severe fear of childbirth was a risk factor for a negative experience of labour induction. OMS compared to MVI generated comparable results among participating women in this randomised controlled trial.
- Open Access
- 1 August 2019
- Published by Elsevier in Women and Birth
- Vol. 32 (4) , 356-363
High-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial
- 1 August 2019
- Published by Elsevier in Women and Birth
- Vol. 32 (4) , 356-363
Open AccessHigh-dose versus low-dose of oxytocin for labour augmentation: a randomised controlled trial